Core Viewpoint - The company, Zhifei Biological Products Co., Ltd., and its wholly-owned subsidiaries have recently obtained an invention patent certificate from the National Intellectual Property Administration of the People's Republic of China for a vaccine and its preparation method [1] Group 1 - The patent is titled "A Vaccine and Its Preparation Method" [1]

Core Viewpoint - Zhifei Biological announced the acquisition of an invention patent for a vaccine and its preparation method, indicating a significant advancement in its product development and potential market competitiveness [1] Company Summary - Zhifei Biological and its wholly-owned subsidiaries, Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd. and Beijing Zhifei Lvzhu Biological Pharmaceutical Co., Ltd., have recently obtained a patent certificate from the National Intellectual Property Administration of the People's Republic of China [1] - The patent is titled "A Vaccine and Its Preparation Method" with the patent number ZL202410156676.3, showcasing the company's innovation in vaccine technology [1]